Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

4E-BP1 Activators

4E-BP1, a critical component of the eukaryotic initiation factor 4E-binding protein (4E-BP) family, plays a pivotal role in regulating protein translation initiation, a fundamental process governing gene expression and cellular function. Functionally, 4E-BP1 acts as a negative regulator of translation by sequestering eukaryotic initiation factor 4E (eIF4E), a key component of the eIF4F complex responsible for cap-dependent translation initiation. In its inactive state, unphosphorylated 4E-BP1 binds tightly to eIF4E, thereby inhibiting its interaction with other initiation factors and ribosomes. This repression of translation initiation contributes to the maintenance of cellular homeostasis by controlling the expression of proteins involved in cell growth, proliferation, and survival.

Activation of 4E-BP1 occurs through phosphorylation-mediated mechanisms orchestrated by various kinases, prominently including the mammalian target of rapamycin complex 1 (mTORC1). Upon activation of mTORC1 in response to growth factors, nutrients, and cellular stress signals, downstream signaling cascades converge on 4E-BP1, leading to its phosphorylation at multiple serine and threonine residues. Phosphorylation of 4E-BP1 induces conformational changes that disrupt its binding to eIF4E, thus releasing eIF4E and allowing it to form the eIF4F complex with other initiation factors. This liberated eIF4F complex subsequently associates with the mRNA 5' cap structure, facilitating ribosome recruitment and translation initiation of mRNAs encoding proteins essential for cell growth and proliferation. Overall, elucidating the intricate mechanisms governing 4E-BP1 activation provides valuable insights into the regulation of protein synthesis and its implications in cellular physiology and disease.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Activates AMPK, which can lead to 4E-BP1 activation via mTOR inhibition.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor that indirectly can lead to 4E-BP1 activation via mTOR pathways.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Activates SIRT1, which can induce 4E-BP1 dephosphorylation and activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Blocks PI3K/Akt pathway, causing mTOR inhibition and subsequent 4E-BP1 activation.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

Activates AMPK, indirectly leading to mTOR inhibition and 4E-BP1 activation.

Torin 1

1222998-36-8sc-396760
10 mg
$245.00
7
(1)

Directly inhibits mTOR, causing 4E-BP1 dephosphorylation and activation.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

AKT inhibitor that can cause downstream mTOR inhibition and 4E-BP1 activation.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor that can indirectly affect 4E-BP1 through cell-cycle regulation.